Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692991 · ClinicalTrials.gov registry record
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 144
- Enrollment target
NCT00692991: Completed study, sponsored by Johns Hopkins University.
NCT00692991 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00692991 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
Coronary artery disease (CAD) is caused by a narrowing of the blood vessels that supply blood and oxygen to the heart. Balloon angioplasty and stent placement are two treatment options for people with reduced heart function caused by CAD. This study will use magnetic resonance imaging (MRI) procedures to evaluate heart function over time in people with CAD who have undergone a balloon angioplasty or stent placement procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 1999-10 |
| Est. Completion | 2016-01 |
What the finished NCT00692991 record still lists
NCT00692991 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00692991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00692991 about?
NCT00692991 is a clinical study titled "Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures". Coronary artery disease (CAD) is caused by a narrowing of the blood vessels that supply blood and oxygen to the heart. Balloon angioplasty and stent placement are two treatment options for people with reduced heart function caused by CAD. This study will use magnetic resonance imaging (MRI) procedur...
What is the current status of trial NCT00692991?
This trial is currently completed. The enrollment target is 144 participants. The study started on 1999-10. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT00692991?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia